Vaccines: latest news

Vaccines resources

  • Vaccines

    HIV vaccine researchers are still looking for a vaccine that would offer a significant degree of protection against HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Vaccines

    The promise of an effective HIV vaccine has always been just over the horizon, but more than 20 years after the identification of HIV, vaccines...

    From: HIV transmission & testing

    Information level Level 4

Vaccines features

Vaccines news from aidsmap

More news

Vaccines news selected from other sources

  • Some chimpanzees infected with AIDS virus may harbor protective, humanlike gene

    When Peter Parham’s postdoc first showed him data suggesting a gene in some wild chimpanzees infected with the AIDS virus closely resembled one that protects humans from HIV, he was skeptical.

    20 hours ago | Science
  • HIV immunity: rare gene differences offer hope for treatment

    Seven years after the ‘Berlin patient’ was cured of HIV, scientists are looking to natural immunity through genetic variation to create vaccine and gene therapies

    12 May 2015 | The Guardian
  • Does Llama Blood Hold the Key to an HIV Vaccine?

    Previous research suggested that llamas given an experimental HIV vaccine produce virus-fighting antibodies that are smaller than those produced by humans. As a result, these smaller antibodies do a better job of latching onto the receptors in human cells where part of the virus lives. An HIV vaccine should target these receptors.

    11 May 2015 | Healthline
  • Improving the effect of HIV drugs by the use of a vaccine

    A vaccine containing a protein necessary for virus replication can boost an HIV-infected patient's immune system, according to clinical research published in the open-access journal Retrovirology. This boost can result in increased effectiveness of antiretroviral drugs.

    29 April 2015 | Eurekalert Inf Dis
  • An HIV Cure and a Vaccine within the Next 15 Years?

    Earlier this year, Bill Gates caused a ripple in the media by expressing optimism that a vaccine and a cure for HIV will become a reality within the next 15 years. From TAG’s perspective, Gates’s buoyancy does have some scientific basis—there have been encouraging signs of progress on both the vaccine and cure fronts in recent years—but the challenges that lie ahead must not be underestimated.

    13 April 2015 | Treatment Action Group
  • Broadly Neutralizing Antibody Suppresses HIV in Clinical Trial

    There is now intense interest in learning whether the blossoming array of broadly neutralizing antibodies (bNAbs) can be put to therapeutic and preventive use. A paper published yesterday in Nature describes encouraging results from a phase I trial involving the bNAb 3BNC117. Reflecting the level of interest in the topic, the paper has attracted extensive press coverage.

    10 April 2015 | TAG
  • In first human study, new antibody therapy shows promise in suppressing HIV infection

    The new study, conducted in Michel Nussenzweig’s Laboratory of Molecular Immunology, finds that administration of a potent antibody, called 3BNC117, can catch HIV off guard and reduce viral loads.

    09 April 2015 | Rockefeller University press release
  • We’re in a renaissance period for the HIV vaccine

    Wayne Koff, chief scientific officer at the International AIDS Vaccine Initiative (IAVI), spoke in an interview about the challenges in developing a vaccine for one of the trickiest and deadliest known viruses, how scientists are getting closer to developing a vaccine for human immunodeficiency virus (HIV), and what makes India attractive for vaccine development.

    01 April 2015 | Hindustan Times
  • Immune Response BioPharma, Inc Announces the FDA has Accepted REMUNE HIV/AIDS Vaccine BLA for Review

    Immune Response BioPharma, Inc., Today provides an update on REMUNE and announces the FDA has accepted the REMUNE HIV/AIDS vaccine BLA (biologics licensing application) for review for therapeutic treatment in adults with HIV/AIDS.

    31 March 2015 | Immune Response BioPharma press release
  • University of RochesterTests HIV Vaccine Pill

    Researchers at the University of Rochester Medical Center are testing a new oral vaccine to prevent infection with HIV, the virus that causes AIDS. The vaccine is unique because it is given as a pill, unlike most HIV vaccines tested to date that have been given as shots.

    20 February 2015 | University of Rochester press release
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.